… classified as APS, according to the Sidney criteria,[1] 285 patients with isolated aPL positivity,
1,397 patients with a clinical suspicion of APS based on the clinical manifestations, 587 …

… impact on the clinical presentation and prognosis of patients with SLE 5… clinical phenotype
and prognosis of aPL-positive patients 8. The AntiPhospholipid Syndrome Alliance for Clinical …

… the rate of antiphospholipid antibodies (aPL) negativisation in patients with antiphospholipid
syndrome (APS), and to evaluate potential new clinical manifestations after negativisation …

… Several nonthrombotic clinical manifestations in APS patients are not included in the current
criteria for diagnosis.[1] These encompass livedo reticularis, thrombocytopenia (usually mild…

… outcome but, in this study, aCL and aβ2GPI status were not independent risk factors [25]. …
Treatment of antiphospholipid syndrome Treatment of the most common clinical manifestations …

… in clinical features over time. APS is a chronic disease and new clinical manifestations may
… Therefore, studying the disease course in patients in each cluster, considering variation in …

… For comparison between groups as well as correlations with clinical manifestations, we used
the Fisher’s exact test, student’s T-test and Pearson Chi Square as appropriate. Values of p …

… In conclusion, APS is a complex thromboinflammatory syndrome with various clinical
manifestations. Primary thrombosis prophylaxis should take an individualized risk stratification …

… of clinical manifestations. Although up to 5% of the population might be positive for
antiphospholipid antibodies … On the other hand, aPL prevalence rates in non-APS patients with …

… criteria for the APS diagnosis as IgA aPLs are not clearly associated with clinical manifestations
of APS [16]. Consequently, we have not screened our study population for IgA aPLs. …